Center for Advanced Vision Science, University of Virginia School of Medicine, Charlottesville, VA, USA.
Department of Ophthalmology, University of Virginia School of Medicine, Charlottesville, VA, USA.
Nat Protoc. 2022 Jun;17(6):1468-1485. doi: 10.1038/s41596-022-00689-4. Epub 2022 Apr 13.
Subretinal injection (SRI) is a widely used technique in retinal research and can be used to deliver nucleic acids, small molecules, macromolecules, viruses, cells or biomaterials such as nanobeads. Here we describe how to undertake SRI of mice. This protocol was adapted from a technique initially described for larger animals. Although SRI is a common procedure in eye research laboratories, there is no published guidance on the best practices for determining what constitutes a 'successful' SRI. Optimal injections are required for reproducibility of the procedure and, when carried out suboptimally, can lead to erroneous conclusions. To address this issue, we propose a standardized protocol for SRI with 'procedure success' defined by follow-up examination of the retina and the retinal pigmented epithelium rather than solely via intraoperative endpoints. This protocol takes 7-14 d to complete, depending on the reagent delivered. We have found, by instituting a standardized training program, that trained ophthalmologists achieve reliable proficiency in this technique after ~350 practice injections. This technique can be used to gain insights into retinal physiology and disease pathogenesis and to test the efficacy of experimental compounds in the retina or retinal pigmented epithelium.
视网膜下注射(SRI)是一种广泛应用于视网膜研究的技术,可用于递送核酸、小分子、大分子、病毒、细胞或生物材料,如纳米珠。本文介绍如何对小鼠进行 SRI。该方案改编自最初为较大动物描述的技术。尽管 SRI 是眼科研究实验室中的常见程序,但对于确定什么是“成功”的 SRI 没有发表的最佳实践指南。为了实现该程序的可重复性,需要进行最佳注射,否则可能会得出错误的结论。为了解决这个问题,我们提出了一种标准化的 SRI 方案,通过对视网膜和视网膜色素上皮进行后续检查来定义“程序成功”,而不仅仅是通过术中终点。根据所递送的试剂,该方案需要 7-14 天完成。我们发现,通过实施标准化培训计划,经过约 350 次练习注射后,受过培训的眼科医生可以可靠地掌握该技术。该技术可用于深入了解视网膜生理学和疾病发病机制,并测试视网膜或视网膜色素上皮中实验化合物的疗效。